Targeting integrin α5β1 ameliorates severe airway hyperresponsiveness in experimental asthma.
Ontology highlight
ABSTRACT: Treatment options are limited for severe asthma, and the need for additional therapies remains great. Previously, we demonstrated that integrin αvβ6-deficient mice are protected from airway hyperresponsiveness, due in part to increased expression of the murine ortholog of human chymase. Here, we determined that chymase protects against cytokine-enhanced bronchoconstriction by cleaving fibronectin to impair tension transmission in airway smooth muscle (ASM). Additionally, we identified a pathway that can be therapeutically targeted to mitigate the effects of airway hyperresponsiveness. Administration of chymase to human bronchial rings abrogated IL-13-enhanced contraction, and this effect was not due to alterations in calcium homeostasis or myosin light chain phosphorylation. Rather, chymas
SUBMITTER: Sundaram A
PROVIDER: S-EPMC5199700 | biostudies-literature | 2017 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA